AAAAAA

   
Results: 1-9 |
Results: 9
Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients
Authors: Pierantozzi, M Pietroiusti, A Sancesario, G Lunardi, G Fedele, E Giacomini, P Frasca, S Galante, A Marciani, MG Stanzione, P
Citation: M. Pierantozzi et al., Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients, NEUROL SCI, 22(1), 2001, pp. 89-91
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
Authors: Venturini, M Michelotti, A Papaldo, P Del Mastro, L Bergaglio, M Lionetto, R Lunardi, G Sguotti, C Frevola, L Donati, S Rosso, R Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients, ANN ONCOL, 12(8), 2001, pp. 1097-1106
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001)
Authors: Venturini, M Michelotti, A Papaldo, P Del Mastro, L Bergaglio, M Lionetto, R Lunardi, G Sguotti, C Frevola, L Donati, S Rosso, R Cognetti, F
Citation: M. Venturini et al., Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. (vol 12, pg 1097, 2001), ANN ONCOL, 12(10), 2001, pp. 1498-1498
Helicobacter pylori induced reduction of acute levodopa absorption in Parkinson's disease patients
Authors: Pierantozzi, M Pietroiusti, A Galante, A Sancesario, G Lunardi, G Fedele, E Giacomini, P Stanzione, P
Citation: M. Pierantozzi et al., Helicobacter pylori induced reduction of acute levodopa absorption in Parkinson's disease patients, ANN NEUROL, 50(5), 2001, pp. 686-687
Sequence effect of epirubicin and paclitaxel treatment on pharmacokineticsand toxicity
Authors: Venturini, M Lunardi, G Del Mastro, L Vannozzi, MO Tolino, G Numico, G Viale, M Pastrone, I Angiolini, C Bertelli, G Straneo, M Rosso, R Esposito, M
Citation: M. Venturini et al., Sequence effect of epirubicin and paclitaxel treatment on pharmacokineticsand toxicity, J CL ONCOL, 18(10), 2000, pp. 2116-2125
Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis
Authors: Leandri, M Lunardi, G Inglese, M Messmer-Uccelli, M Mancardi, GL Gottlieb, A Solaro, C
Citation: M. Leandri et al., Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis, J NEUROL, 247(7), 2000, pp. 556-558
Reduction of cisplatin nephrotoxicity by procainamide: Does the formation of a cisplatin-procainamide complex play a role?
Authors: Viale, M Vannozzi, MO Pastrone, I Mariggio, MA Zicca, A Cadoni, A Cafaggi, S Tolino, G Lunardi, G Civalleri, D Lindup, WE Esposito, M
Citation: M. Viale et al., Reduction of cisplatin nephrotoxicity by procainamide: Does the formation of a cisplatin-procainamide complex play a role?, J PHARM EXP, 293(3), 2000, pp. 829-836
Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients
Authors: Esposito, M Venturini, M Vannozzi, MO Tolino, G Lunardi, G Garrone, O Angiolini, C Viale, M Bergaglio, M Del Mastro, L Rosso, R
Citation: M. Esposito et al., Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients, J CL ONCOL, 17(4), 1999, pp. 1132-1140
Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship
Authors: Balestrino, M Rebaudo, R Lunardi, G
Citation: M. Balestrino et al., Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship, BRAIN RES, 816(1), 1999, pp. 124-130
Risultati: 1-9 |